KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Other financing activities (2020 - 2025)

Oscar Health (OSCR) has disclosed Other financing activities for 3 consecutive years, with $2.0 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other financing activities rose 135.37% year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Sep 2024, down 75.37%, and an annual FY2022 reading of $7.0 million, changed N/A over the prior year.
  • Other financing activities was $2.0 million for Q3 2023 at Oscar Health, up from $471000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $9.4 million in Q3 2021 and bottomed at -$9.4 million in Q4 2021.
  • Average Other financing activities over 3 years is $1.4 million, with a median of $2.0 million recorded in 2023.
  • Peak annual rise in Other financing activities hit 160.45% in 2022, while the deepest fall reached 160.45% in 2022.
  • Year by year, Other financing activities stood at -$9.4 million in 2021, then soared by 160.45% to $5.7 million in 2022, then plummeted by 64.63% to $2.0 million in 2023.
  • Business Quant data shows Other financing activities for OSCR at $2.0 million in Q3 2023, $471000.0 in Q1 2023, and $5.7 million in Q4 2022.